Investment
Features
FeesSafety
Academy
More
Pluang+

Astellas presents new cancer treatment data at ESMO 2026, highlighting advances in bladder, gastric, and prostate cancers.

Market News
06 Oct 2026
PRNewsWire
View Source
Bullish
Astellas presents new cancer treatment data at ESMO 2026, highlighting advances in bladder, gastric, and prostate cancers.

Astellas Pharma announced 21 oncology abstracts to be presented at ESMO 2026, showcasing data on treatments for bladder, gastric, prostate, lung, and pancreatic cancers. Key highlights include durable survival benefits from PADCEV (enfortumab vedotin) plus pembrolizumab in advanced bladder cancer and reinforced evidence for zolbetuximab (VYLOY) in gastric cancer treatment decisions. The presentations also cover ongoing trials for new therapies targeting hard-to-treat cancers, reflecting Astellas' commitment to advancing cancer care. These findings may influence future treatment standards and patient outcomes.

Astellas' oncology data advances cancer care, here is Pluang's health sector snapshot as of Oct 07, 2026 04:23 WIB: Among 100 priced US health stocks, 41 rose and 59 fell. Illumina (ILMN) gained 7.68% at USD 294.00 with a typical hold time of 84 days and 78% buy orders, contrasting with Citius Pharmaceuticals (CTXR) which dropped 7.65% to USD 0.48 and had a much shorter hold time of 17 days with 98% buy orders. Moderna (MRNA) also declined 7.34% to USD 188.30, holding for 59 days on average with 76% buy orders.

More News

Ethereum holds steady near $2,700 amid $414M in long liquidations and $640M in shorts at risk

Ethereum holds steady near $2,700 amid $414M in long liquidations and $640M in shorts at risk

Ethereum's price remained stable around $2,700 with minimal daily movement, but derivatives data reveals significant leverage on both sides. About $414.1 million in long positions and $640.6 million in short positions are in potential liquidation zon...

Technical Signals
Neutral
4 hours ago
Constellation Brands shares drop 14%, now trading at 9x earnings with strong revenue and EPS beat.

Constellation Brands shares drop 14%, now trading at 9x earnings with strong revenue and EPS beat.

Constellation Brands saw its shares fall 14%, now trading at a compelling 9 times earnings. The company reported 6% revenue growth and a 3% earnings per share (EPS) beat, driven mainly by strong beer sales despite margin pressure from increased marke...

Company Fundamentals
Bullish
4 hours ago
XRP may skip final rally and drop to $1.27 support amid tightening range below $1.65 resistance.

XRP may skip final rally and drop to $1.27 support amid tightening range below $1.65 resistance.

XRP is trading below a key resistance near $1.65 and may either make a final push toward $1.70 or begin a pullback directly to $1.27 support, with a deeper drop to $1.10 possible. A breakout above $1.80 could turn $1.65 into a new support level, sign...

Technical Signals
Neutral
4 hours ago
Abstract to shut down by Dec 15, 2026; users urged to move assets; Winklevoss files Zcash ETF; Coinbase launches crypto price prediction markets.

Abstract to shut down by Dec 15, 2026; users urged to move assets; Winklevoss files Zcash ETF; Coinbase launches crypto price prediction markets.

Abstract announced it will shut down on December 15, 2026, urging users to relocate their assets before the deadline. Meanwhile, Winklevoss has filed for a Zcash (ZEC) exchange-traded fund (ETF), signaling growing interest in crypto investment produc...

Market News
Neutral
4 hours ago
$9.85M leveraged Ether long position liquidated as ETH price falls below $2,600

$9.85M leveraged Ether long position liquidated as ETH price falls below $2,600

A leveraged long position of 3,728 Ether (ETH), valued at $9.85 million, was fully liquidated within three minutes after Ether's price dropped below $2,600. This rapid liquidation highlights the risks of leveraged trading, where a sharp price decline...

Technical Signals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App